Prokaryotic expression and immunogenicity in rabbit of Ebola virus VP40 matrix protein

DOI: 10.18805/ijar.v0iOF.8477    | Article Id: B-630 | Page : 121-125
Citation :- Prokaryotic expression and immunogenicity in rabbit of Ebola virus VP40matrix protein .Indian Journal of Animal Research.2018.(52):121-125

Yinbiao Wang, Xiao Liu,  Xingdong Yang, Ling Tao, Pengwei Xu,  Xia Gao, Huijun Li, Zhongzhi Yang and Weidong Wu.

Address :

School of Public Health, Xinxiang Medical University, Xinxiang, 453003, China.

Submitted Date : 1-10-2016
Accepted Date : 11-02-2017


Ebola hemorrhagic fever is among severe and fatal viral hemorrhagic fevers and a global health concern. Here, we constructed a prokaryotic expression plasmid pET32a-VP40 for the large-scale expression of VP40 in E. coli Rosetta (DE3) cells. Water-soluble protein was obtained through optimization of the expression temperature, time and IPTG concentrations. After purification through Ni-NTA affinity chromatography, VP40 protein was applied to immunize rabbit for the analysis of immunogenicity and the production of polyclonal antibodies. Western blot showed that recombinant VP40 protein could be recognized by anti-His6-tag MAb and rabbit polyclonal antibodies against VP40 protein. Polyclonal antibody titers in ELISA reached 1:51200. Moreover, the produced rabbit polyclonal antibodies could react specifically with VP40 protein expressed in BHK-21 cells by transfection of pcDNA-eGFP-VP40 in IPMA. The preparation of VP40 protein and its polyclonal antibodies laid the basis for developing immunoassays for EBOV detection.


Characterization of polyclonal antibodies Expression Immunogenicity VP40 protein ZEBOV.


  1. Adu-Gyamfi, E.; Soni, S.P.; Xue, Y.; Digman, M.A.; Gratton, E.; Stahelin, R.V. (2013). The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress. The Journal of Biological Chemistry, 288: 5779-5789.
  2. Baize, S.; Pannetier, D.; Oestereich, L.; Rieger, T.; Koivogui, L.; Magassouba, N.; Soropogui, B.; Sow, M.S.; Keita, S.; De Clerck, H.; Tiffany, A.; Dominguez, G.; Loua, M.; Traore, A.; Kolie, M.; Malano, E.R.; Heleze, E.; Bocquin, A.; Mely, S.; Raoul, H.; Caro, V.; Cadar, D.; Gabriel, M.; Pahlmann, M.; Tappe, D.; Schmidt-Chanasit, J.; Impouma, B.; Diallo, A.K.; Formenty, P.; Van Herp, M.; Gunther, S. (2014). Emergence of Zaire Ebola virus disease in Guinea. The New England Journal of Medicine, 371: 1418-1425.
  3. Drosten, C.; Gottig, S.; Schilling, S.; Asper, M.; Panning, M.; Schmitz, H.; Gunther, S. (2002). Rapid Detection and Quantification of RNA of Ebola and Marburg Viruses, Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus, Dengue Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCR. Journal of Clinical Microbiology, 40: 2323-2330.
  4. Duan, D.; Fan, K.; Zhang, D.; Tan, S.; Liang, M.; Liu, Y.; Zhang, J.; Zhang, P.; Liu, W.; Qiu, X.; Kobinger, G.P.; Fu Gao, G.; Yan, X. (2015). Nanozyme-strip for rapid local diagnosis of Ebola. Biosensors and Bioelectronics, 74: 134-141.
  5. Feldmann, H.; Klenk, H.D. and Sanchez, A. (1993). Molecular biology and evolution of filoviruses. Archives of Virology, 7: 81-100.
  6. Gibb, T.R.; Norwood, D.A.; Woollen, N. and Henchal, E.A. (2001). Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan. Journal of Clinical Microbiology, 39: 4125-4130.
  7. Jain, T.; Kadam, M.; Jain, A. and Sarkhel, B.C. (2013). Prokaryotic expression of N gene of infectious bronchitis virus and assessment of its immunogenicity and antigenicity. Indian Journal of Animal Research, 47(4): 292-300.
  8. Jin, Q.Y.; Yang, J.F.; Lu, Q.X.; Guo, J.Q.; Deng, R.G.; Wang, Y.B.; Wang, S.H.; Wang, S.F.; Chen W.; Zhi, Y.B.; Wang, L.; Yang, S.Z.; 
  9. Kaushik, A.; Tiwari, S.; Dev Jayant, R.; Marty, A. and Nair, M. (2016). Towards detection and diagnosis of Ebola virus disease at point-of-care. Biosensors and Bioelectronics, 75: 254-272.
  10. Ksiazek, T.G.; Rollin, P.E.; Jahrling, P.B.; Johnson, E.; Dalgard, D.W.; Peters, C.J. (1992). Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. Journal of Clinical Microbiology, 30: 947-950.
  11. Ksiazek, T.G.; West, C.P.; Rollin, P.E.; Jahrling, P.B. and Peters, C.J. (1999). ELISA for the Detection of Antibodies to Ebola Viruses. The Journal of Infectious Diseases, 179: 192-198.
  12. Lucht, A.; Grunow, R.; Möller, P.; Feldmann, H. and Becker, S. (2003). Development, characterization and use of monoclonal VP40-    antibodies for the detection of Ebola virus. Journal of Virological Methods, 111: 21-28.
  13. Niikura, M.; Ikegami, T.; Saijo, M.; Kurane, I.; Miranda, M.E.; Morikawa, S. (2001). Detection of Ebola viral antigen by enzyme-    linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein. Journal of Clinical Microbiology, 39: 3267-3271.
  14. Noda, T.; Ebihara, H.; Muramoto, Y.; Fujii, K.; Takada, A.; Sagara, H.; Kim, J.H.; Kida, H.; Feldmann, H.; Kawaoka, Y. (2006). Assembly and budding of Ebolavirus. PLoS Pathogens, 2: 0864-0872.
  15. Peng, Z.;Ma, T.; Pang, D.; Su, D.; Chen, F.; Chen, X.; Guo, N.; Ouyang, T.; Ouyang, H.; Ren, L. (2016). Expression, purification and antibody preparation of PCV2 Rep and ORF3 proteins. International Journal of Biological Macromolecules, 86: 277-281.
  16. Rajak, H.; Jain, D.K.; Singh, A.; Sharma, A.K. and Dixit, A. (2015). Ebola virus disease: past, present and future. Asian Pacific Journal of Tropical Biomedicine, 5: 337-343.
  17. Saijo, M.; Niikura, M.; Ikegami, T.; Kurane, I.; Kurata, T.; Morikawa, S. (2006). Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clinical and Vaccine Immunology, 13: 444-451.
  18. Shears, P. and O’Dempsey, T.J. (2015). Ebola virus disease in Africa: epidemiology and nosocomial transmission. The Journal of Hospital Infection, 90: 1-9.
  19. Timmins, J.; Schoehn, G.; Ricard-Blum, S.; Scianimanico, S.; Vernet, T.; Ruigrok, R.W.H.; Weissenhorn, W. (2003). Ebola Virus Matrix Protein VP40 Interaction with Human Cellular Factors Tsg101 and Nedd4. Journal of Molecular Biology, 326: 493-502.
  20. Tsuda, Y.; Parkins, C.J.; Caposio, P.; Feldmann, F.; Botto, S.; Ball, S.; Messaoudi, I.; Cicin-Sain, L.; Feldmann, H.; Jarvis, M.A. (2015). A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose. Vaccine, 33: 2261-2266. 
  21. Vijay, N.; Harikrishna, P.; Ghosh, S.K. and Bhure, S.K. (2015). Molecular cloning and expression of buffaloESX-1gene: A marker for X-chromosome bearing spermatozoa. Indian Journal of Animal Research, 49: 442-447.
  22. Williams, G.S.; Naiene, J.; Gayflor, J.; Malibiche, T.; Zoogley, B.; Frank, W.G. Jr.; Nayeri, F. (2015). Twenty-one days of isolation: A prospective observational cohort study of an Ebola-exposed hot zone community in Liberia. The Journal of Infection, 71: 150-157.
  23. Zhang, G.P. (2012). Development of an immunochromatographic strip for the detection of antibodies against Porcine circovirus-2. Journal of Veterinary Diagnotic Investigation, 24(6): 1151-1157. 

Global Footprints